Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COMPASS Pathways Plc
CMPS
Healthcare
Biotechnology
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary...
psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:CMPS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Oct 31, 2024 9:15pm
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
Breaking News: $CMPS Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript2024-10-31 21:00:25 ET Image source: The Motley Fool. Compass Pathways Plc (NASDAQ: CMPS) Q3 2024 Earnings Call Oct 31,
...more
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Oct 31, 2024 5:15pm
Trend Tracker for (CMPS)
JUST IN: $CMPS Trend Tracker for (CMPS)2024-10-31 14:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry
...more
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 02, 2024 4:28pm
COMPASS Pathways plc: Advancing Psilocybin Therapy with Prom
https://beyondspx.com/2024/07/31/compass-pathways-plc-advancing-psilocybin-therapy-with-promising-ptsd-data-and-pivotal-trd-trials-on-track/
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jun 12, 2024 4:15pm
Should You Buy the Dip on Compass Pathways Stock?
NEWS: $CMPS Should You Buy the Dip on Compass Pathways Stock?2024-06-12 06:25:00 ET If you can do the mental work to separate your sentiment about a stock from its recent price action, buying the dip
...more
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jul 17, 2023 5:00am
COMPASS Pathways announces publication of positive data from
NEWS: $CMPS COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal
...more
(10)
•••
FukDaFed
X
View Profile
View Bullboard History
Post by
FukDaFed
on Feb 22, 2022 8:36pm
Buy for me here, stock seems cheap.
Stage 3 trials
(30)
•••
MushLove
X
View Profile
View Bullboard History
Post by
MushLove
on Dec 12, 2021 4:00pm
The declining sp is affecting my mental health
This stock is not getting very much love.
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Nov 23, 2021 7:56am
Compass Pathways Granted Its Tenth Overall Patent Related To
Compass Pathways this morning issued a brief release, indicating it has been granted a fifth patent in the United States. The patent is related to what is referred to as crystalline psilocybin, and
...more
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Jun 28, 2021 7:38am
Compass Pathways Closes Enrollment For Phase IIb Psilocybin
Compass Pathways this morning provided a brief update to the market on the latest status of its ongoing phase IIb psilocybin therapy trial. The trials are being conducted to test the efficacy of
...more
(8)
•••
KandiBirdBoy
X
View Profile
View Bullboard History
Post by
KandiBirdBoy
on Apr 30, 2021 11:14am
RED LIGHT HOLLAND $TRIP 🍄🍄🍄🍄🍄$TRUFF
Entering Brazil , Oregon Rec Markets , Netherlands!!
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Mar 10, 2021 1:55pm
David Nutt: Amanita Muscaria Due For More Research – The Dai
Today host Cassandra Leah sits down with Dr David Nutt, a highly experienced neuropsychopharmacologist, the chair of the scientific advisory board for Compass Pathways, and a director of Psyched
...more
(36)
•••
BryceCanada
X
View Profile
View Bullboard History
Post by
BryceCanada
on Mar 08, 2021 7:13pm
Great YT analysis on TRIP/TRUFF
https://youtu.be/k_2jeRmHL0I
(7)
•••
TraderLife
X
View Profile
View Bullboard History
Post by
TraderLife
on Feb 22, 2021 5:56pm
CMPS Stronger Move Than MMED
(3)
•••
Chris333
X
View Profile
View Bullboard History
Post by
Chris333
on Feb 03, 2021 11:07am
funny
I would need therapy after tripping with someone sober (watching me) and just laying on a table for 8 hours. Funny. That would be horrible.
(902)
•••
CommonCentsforDollars
X
View Profile
View Bullboard History
Post by
CommonCentsforDollars
on Jan 22, 2021 3:23pm
Horizons ETFs to Launch World's First Psychedelics-Focused E
Horizons ETFs to Launch World's First Psychedelics-Focused ETF https://markets.businessinsider.com/news/stocks/horizons-etfs-to-launch-world-s-first-psychedelics-focused-etf-1029994672 Maybe
...more
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >